DGAP-Adhoc: HELMA Eigenheimbau AG reports record new order intake in 2021
2022. január 11., kedd, 13:04
DGAP-Ad-hoc: HELMA Eigenheimbau AG / Key word(s): Incoming Orders HELMA Eigenheimbau AG reports record new order intake in 2021 In this context it is to be noted that, in relation to the Efficiency House 55, the unexpected discontinuation of the subsidy for newbuilds as of January 31, 2022 has led to marked accelerated purchasing effects on new order intake in the fourth quarter of 2021, which are estimated to amount to up to 10 % of the total new order intake. Even excluding these accelerated purchasing effects, however, new order intake would have stood above the EUR 400 million level, representing growth of around 30 %. The company"s guidance from July 2021 envisaged growth in new order intake for the past financial year in the magnitude of 20-25%. All business segments contributed to this pleasing sales result, as can be seen from the overview of new order intake under the following link: https://ir.helma.de//download/companies/helmaeigenheimbau/Figures/2021_helma_new_order_intake.pdf The new orders that have been received will be realised mainly in 2022 and 2023. This gives the HELMA Group an excellent basis for the growth it targets over the coming years.
|
Language: | English |
Company: | HELMA Eigenheimbau AG |
Zum Meersefeld 4 | |
31275 Lehrte | |
Germany | |
Phone: | +49 (0)5132/8850-345 |
Fax: | +49 (0)5132/8850-111 |
E-mail: | [email protected] |
Internet: | www.helma.de |
ISIN: | DE000A0EQ578 |
WKN: | A0EQ57 |
Indices: | Scale 30 |
Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Scale), Hamburg, Hanover, Stuttgart, Tradegate Exchange |
EQS News ID: | 1267348 |
End of Announcement | DGAP News Service |
1267348 11-Jan-2022 CET/CEST
Közzétételek - archívum
-
» Laxxon Medical to Participate in the BIO CEO & Investor Conference
[2023.02.02. 20:15]
-
» PJSC Magnitogorsk Iron and Steel Works: MMK notifies on additional extension of consent solicitation process
[2022.06.30. 13:00]
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]